Invesco Ltd. - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$1,873,000
+1.7%
167,178
-0.1%
0.00%0.0%
Q2 2017$1,841,000
+22.4%
167,344
+9.1%
0.00%
Q1 2017$1,504,000
+4.5%
153,430
+15.1%
0.00%
Q4 2016$1,439,000
-67.6%
133,287
-69.3%
0.00%
-100.0%
Q3 2016$4,446,000
-65.0%
433,789
-55.4%
0.00%
-60.0%
Q2 2016$12,705,000
+220.9%
972,840
+170.3%
0.01%
+150.0%
Q1 2016$3,959,000
+62.0%
359,941
+35.5%
0.00%
+100.0%
Q4 2015$2,444,000
+33.7%
265,621
+0.9%
0.00%0.0%
Q3 2015$1,828,000
-24.1%
263,310
+7.3%
0.00%0.0%
Q2 2015$2,410,000
+17.0%
245,474
+5.6%
0.00%0.0%
Q1 2015$2,060,000
+69.8%
232,513
+68.0%
0.00%
Q4 2014$1,213,000
+244.6%
138,401
+170.7%
0.00%
Q3 2014$352,000
+87.2%
51,123
+43.0%
0.00%
Q2 2014$188,000
+15.3%
35,7590.0%0.00%
Q1 2014$163,000
-59.2%
35,759
-55.0%
0.00%
Q4 2013$400,000
+38.4%
79,433
+39.5%
0.00%
Q3 2013$289,000
+100.7%
56,934
+95.6%
0.00%
Q2 2013$144,00029,1030.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders